ENTITY
UOB-Kay Hian

UOB-Kay Hian (UOBK SP)

312
Analysis
Financials • Singapore
UOB-Kay Hian is a Singapore-based financial services group offering brokerage services, private wealth management, investment management, and financial research. It provides a wide range of products including equities, bonds, derivatives, and structured products, alongside corporate finance advisory and equity underwriting. The company traces its roots to Kay Hian & Co. in the early 1900s and is headquartered in Singapore.
more
•26 Aug 2026 17:50•Syndicated

Singapore Market Roundup (26-Aug-2026): UOB Kay Hian downgrades DBS to 'hold', maintains 'buy' on

UOB Kay Hian downgrades DBS to 'hold', maintains 'buy' on OCBC. Huationg's target price cut to 88 cents; Nam Cheong remains 'buy' at $2.05 target.

Share
•24 Aug 2026 18:22•Syndicated

Singapore Market Roundup (24-Aug-2026): RHB's Yeo lowers Food Empire target price to $3.08,

RHB's Yeo maintains a positive view on Food Empire, lowering the target price to $3.08. PhillipCapital cuts ComfortDelGro's target to $1.21 and...

Share
•14 Aug 2026 17:47•Syndicated

Singapore Market Roundup (14-Aug-2026): RHB and DBS keep 'neutral' stance on Wilmar after strong

RHB and DBS keep a 'neutral' outlook on Wilmar despite strong 2QFY2026 results, while analysts are optimistic about Frencken and Singtel's earnings.

Share
•29 Jul 2026 17:48•Syndicated

Singapore Market Roundup (29-Jul-2026): JP Morgan stays 'underweight' on Seatrium amid profit

JP Morgan stays 'underweight' on Seatrium; UOBKH downgrades Aztech to 'hold' amid weak outlook; analysts remain positive on CSE Global post-site...

Share
•28 Jul 2026 18:02•Syndicated

Singapore Market Roundup (28-Jul-2026): Analysts stay bullish on CSE Global after recent visit.

Analysts are optimistic on CSE Global post-site visit, positive on iFAST after 2QFY2026 growth, but cautious on Raffles Medical after weak 1HFY2026...

Share
x